OOIR: Observatory of International Research

Papers

(The median citation count of Nephrology Dialysis Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Erratum to: FC041 tubular epithelial cell polyploidy is essential to survive AKI but contributes to CKD progression	178
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases	122
MO380: Bio-Conductivity Measurement for Electrical Impedance Tomography (EIT) in Chronic Kidney Disease—A Non-Invasive and Portable Monitoring Approach	87
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients	81
Immunoengineering for autoimmune-kidney disease	76
Anti-C1Q monitoring predicts relapses of lupus nephritis	75
#1281 Torque teno virus load in kidney transplantation: association with donor and recipient characteristics and clinical follow-up data	73
#1063 Impact of geriatric nutritional risk index on renal function in elderly chronic kidney disease patients treated with SGLT2 inhibitors	64
#2649 Investigation of the Rac1-SGK1 pathway and therapeutic effects of finerenone and Rac1 inhibition in a Fabry disease podocyte model	62
#2398 Exogenous a-Klotho supplementation significantly prolongs survival in a mouse model of alport syndrome, with comparable outcomes to RASi	57
#2706 Genetically determined reduction of renal carbonic anhydrase 12 is associated with decreased kidney function and increased serum urate	57
#291 Prevalence and patterns of intradialytic arterial oxygen saturation instability: observations in a large U.S. hemodialysis cohort	56
#2590 Evolutionary origins of polycystic kidney disease genes: insights from emerging phylogenomic methodologies	55
#3257 Urinary metabolomics in nephrotic syndrome: the experience of “Fondazione Policlinico Universitario A. Gemelli”	54
#2588 Renal trajectories in the french RaDiCo Alport syndrome cohort	54
#1881 Evaluating the clinical and economic impact of SGLT-2 inhibitors for CKD management in the UK: insights from the IMPACT CKD microsimulation model	49
#2889 Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart	49
#949 Vitamin K dependent proteins and bone quality in the first year after kidney transplantation	47
#3063 Real-world utility of the International IgA Nephropathy Prediction Tool in a tertiary referral centre of nephrology	44
#1685 Multimodal spatial profiling of microvascular inflammation in kidney allografts	44
#2638 Recombinant zoster vaccine (RZV) confers persistent immune responses with no safety concerns 4 to 8 years after vaccination of adults with renal transplant	44
#3134 Implementation of an iohexol-based GFR-measurement in clinical routine	44
#1922 Association of parathyroid hormone and alkaline phosphatase with fracture risk in patients with chronic kidney disease not on dialysis	44
#960 A single-centre service evaluation of patient-centred twice-weekly dialysis delivery	44
#3385 The short and long-term accuracy of urinary C-C motif Chemokine-14 in an ICU population	42

#1796 The impact of metabolic syndrome components on renal function in patients with heart failure	41
#2271 SGLT2 inhibition triggers aestivation-like metabolic switches for water conservation in patients with heart failure—results from DAPA-Shuttle1, a randomized, placebo-controlled trial	41
#623 SGLT2 inhibitors in adult patients with Alport syndrome: a single center Italian experience	41
#1727 Kidney function associated with mortality in hantavirus infection: a cohort study in BRAZIL	38
#2731 Legacy effect of pretransplant immunosuppression in kidney transplant recipients with crescentic glomerulonephritis	38
#2266 Integrating palliative care into nephrology: a single-center “action-research” process	35
#3268 Cognitive decline in hemodialysis patients : a prospective cross-sectional study analysing sociodemographic and clinical determinants	33
#3716 Change in mGFR following bariatric surgery: A case-crossover study	33
#3777 Roles of antiHLA antibodies in the onset of MACE in a population of patients on dialysis and on the waiting list for kidney transplant. A retrospective single-center study	33
#3842 Significant association between B lymphocytes and their subpopulations with peripheral T follicular cells is evident in patients with systemic lupus erythematosus (SLE) at remission	33
#147 Evidence of impaired myocardial perfusion reserve in asymptomatic non-diabetic patients with advanced CKD	33
#2190 The protective effects of a ketogenic diet in experimental glomerulonephritis are independent of the Hca2 receptor	33
#450 Comparison of Thymoglobulin® vs Grafalon® as induction treatment in kidney transplantation with maastricht type III donor	32
#1644 Evaluation of clinical consequences in diverse forms of fistula elevation procedure	32
#3075 Comparison of β-blocker with other anti-hypertensive drugs in patients with chronic kidney disease in Korea: a national health insurance data	32
#3389 Ultrasound evaluation of fluid overload in hemodialysis patients: comparison between VExUS score and lung ultrasound in a cross-sectional study	32
#2661 Interplay between polymorphism in the EDNRA gene and endothelin-1 concentration in the blood of patients with chronic kidney disease	32
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population	31
#1100 “Unraveling the genetic complexity of autosomal dominant polycystic kidney disease: insights from gene conversion events”	31
#3313 A novel identification of anti-hypertensive drug spironolactone as an inhibitor of paraoxonase 2 lactonase and anti-ROS activities	31
#2491 Exploring the association between non-alcoholic fatty liver disease and chronic kidney disease: insights from NHANES 1999–2016	31
#3480 Dehydration and hypertension differently prime intrinsic and pre-renal AKI	30
#1519 Granulomatous interstitial nephritis in a patient with metastatic melanoma on target therapy with dabrafenib and trametinib: a case report	30
#3387 Hepatitis, acute kidney injury and myositis due to atorvastatin	29
#1085 Acute kidney injury in Iraqi cancer patients treated with immune checkpoint inhibitors. (project ICI-AKI Iraq) interim analysis	29
#1715 Online prediction of dialysis adequacy failure in hemodialysis	29
#1793 Renal protective effect of SGLT2 inhibitors in patients with Fabry disease	29
#3838 Hungry bone syndrome (HBS) as an outcome of parathyroidectomy as a treatment of hyperparathyroidism in a third level hospital in a medium-income country	29
#1795 Next-generation sequencing in chronic kidney disease of unknown etiology: a step toward precision medicine	29
#3692 Granulomatous interstitial nephritis and immunodeficiency—a link to remember	29
#3225 Integrating telemedicine into peritoneal dialysis: a holistic model for palliative care in advanced CKD	28
Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria	28
#3368 The implementation of a multi-faceted cardio-renal service on heart failure and renal outcomes: a retrospective cohort study	28
On the fragility of outcome measures of two individual patient data analyses from randomized controlled trials on online haemodiafiltration	28
#2782 Clinician usage and perception of an AI-based model predicting peritoneal dialysis dropouts	28
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity	27
Cognitive deficits associate with cerebral hypoxia during hemodialysis	27
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications	27
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial	27
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections	26
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients	26
#1048 Why are felids at such a high risk of chronic kidney disease?	26
Uromodulin biology	26
MO197: Change in the Level Of NFKBP65 Gene Expression in the Myocardium and Kidneys of Wistar Rats and Spontaneously Hypertensive Rats (SHR) That Received Diet Rich in NACL	26
MO1005: Analysis of Expression of Immune System Genes that are Responsible for Activation and Inhibition of T-Cell Immune Response in Renal Transplant Recipients after Extracorporeal Photochemotherapy	26
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)	26
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy	25
FC029: A Multivariate Model Identifies Genotype, Hypertension and Kidney Length as Independent Baseline Predictors of Disease Progression in a Longitudinal Autosomal Dominant Polycystic Kidney Disease	25
MO227: Anca-Associated Vasculitis Following Pfizer-Biontech COVID-19 Vaccine: True Association or Circumstantial?	25
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION	25

FC077: Cystatin C Testing Improves Risk Stratification Associated with Chronic Kidney Disease Without Adopting Age-Adapted Diagnostic Thresholds: A UK Biobank Study	25
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES	24
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS	24
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe	24
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	24
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?	24
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease	24
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease	24
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective	24
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS	23
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?	23
#1818 Association of combined systemic inflammatory indices with the severity and outcome of tunnelled hemodialysis catheter-related bacteremia	23
#2294 Muscle ultrasound as a tool for morphofunctional assessment in patients with chronic kidney disease	23
MO1029: Is there a Relationship Between Fibroblast Growth Factor 23 and Blood Pressure in Children with Chronic Kidney Disease?	23
#2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications	23
MO916: Anxiety and Depression Among Dialysis Centre Staff and Haemodialysis Patients During the COVID-19 Pandemic	23
#2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE	23
#4585 POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: COMPARISON OF RISK AND PROGNOSTIC FACTORS BETWEEN KIDNEY AND OTHER ORGAN TRANSPLANT RECIPIENTS	23
MO142: Urinary Hemopexin As a Marker of Lupus Activity Among Egyptian SLE Patients with Proliferative Lupus Nephritis	23
#2118 Monitoring hemodynamics in dialysis: on the feasibility of semi-continuous and multifrequency thoracic bioimpedance measurements by a wearable device	22
#3140 THE WEST OF SCOTLAND AND THROMBOTIC MICROANGIOPATHY	22
#5285 SERUM IRON AND NUTRITIONAL STATUS ARE ASSOCIATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE	22
#2695 A Polycystin-1-Bicaudal C1 complex regulates focal adhesion function through integrin beta-1, F-actin organisation and local translation in HKE cells	21
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER	21
MO405: Leucine-Rich Alpha-2-Glycoprotein as a Potential Marker of Mesangial Cell Proliferation in Immunoglobulin a Nephropathy	21
MO144: Behind the Scenes: A Year in an Onco-Nephrology Outpatient Clinic in Italy	21
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY	21
#1350 Finerenone in real-life clinical practice: first results from a pilot study	21
#1834 Prevalence of nephrolithiasis in patients with idiopathic hypercalciuria after two decades of follow-up	21
MO1019: Sigma-1 Receptor Agonists are Protective in a Rat Model of Kidney Transplantation	21
#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS	21
MO273: Water Restriction and Age Increase the Risk of Triple Whammy-Induced Acute Kidney Injury	21
MO048: Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases	21
MO522: The Effect of Statin on Anemia in Patients With End-Stage Kidney Disease Receiving Hemodialysis: A Systematic Review and Meta-Analysis	20
MO753: Marinobufagenin Predicts Intradialytic Hypotension Episodes in Prevalent Haemodialysis Patients	20
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE	20
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES	20
#3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN	20
#4720 SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN	20
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD	20
#3166 RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS	20
#651 Diagnostiс criteria of the functional state of the kidneys in patients with type 2 diabetes mellitus	20
#761 Effect of ketoanalogue-supplemented very low protein diet in the need to initiate renal replacement in chronic kidney disease patients	20
#5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE	20
MO675: A New in Vivo Multi-Photon Microscopy Based Approach to Study the Peritoneal Membrane Changes Induced by Peritoneal Dialysis	20
#5349 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY	20
MO766: Sodium Citrate Versus Heparin Locking Solutions for Tunnelled Haemodialysis Catheters: A Retrospective Analysis	20
MO826: Long-Term Impact of COVID-19 Pandemic on HD Adequacy and Patient Care in Alexandria, Egypt: A Multi-Centre Study	20
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS	19
#1315 Management and long-term outcome of recurrent idiopathic FSGS in pediatric renal transplant recipients	19
#3121 THE EFFECTIVENESS OF A GLUTEN-FREE DIET IN PATIENTS WITH IGA NEPHROPATHY	19
#1846 Oxalate nephropathy in diabetic kidney disease: another factor to take into account?	19
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS	19
#1962 Development of triple-whammy induced pre-renal AKI is highly dependent on the hydration status	19
#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHRONIC KIDNEY DISEASE (CKD)	19
#1076 DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/ P66shc signaling pathway in diabetic kidney disease	19
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE	19
#1716 IgA nephropathy: our center's experience	19
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS	19
#2251 Long-term systolic blood pressure variability as an independent risk factor for cardiovascular events in kidney transplant recipients	19
#1795 Diverse histological findings of kidney injury in cancer patients on immunotherapy- impact on clinical management	19
#635 Effect of multi-biomarker panels based on urinary N-terminal osteopontin on prediction of diabetic kidney disease in patients with diabetes mellitus	19
MO841: Anxiety and Depression in Maintenance Hemodialysis Patients: Prevalence and Their Effects on Health-Related Quality of Life	18
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS	18
#972 A Novel Single Compound from Chinese Herbs as a Potential Candidate for Reducing obesity induced diabetic nephropathy via ATF3-RARRES1 axis pathway	18
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?	18
#4554 FRAX® ASSOCIATION, BONE DENSITOMETRY, BIOCHEMICAL PARAMETERS OF BONE MINERAL METABOLISM AND ADVANCED CHRONIC KIDNEY DISEASE	18
#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD	18
MO869: SARS-COV-2 Neutralizing Antibodies in Patients on Hemodialysis After Vaccination	18
#2529 The role of the circadian clock system in the transition from acute kidney injury to chronic kidney disease	18
#821 Kibra mediates the activation of hippo by classic signal pathway related to NPHP1 defect	18
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	18
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?	18
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION	18
#1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project	18
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES	18
#2556 Therapeutic monitoring in patients with APRT deficiency using UPLC-MS/MS-based plasma assay	18
FC033: Genome-Wide Association Meta-Analysis Identifies Novel Loci for Kidney Failure	18
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY	17
#2740 Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease	17

#560 The representation of multimorbidity and frailty in the development and validation of kidney failure risk prediction models – a systematic review	17
#1839 Evaluating the severity of restless legs syndrome in chronic kidney disease patients across different renal replacement therapies	17
#860 The role of immunocorrection in the treatment of patients chronic pyelonephritis	17
#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY	17
#2699 Rare glomerular microangiopathy: clinicopathological characteristics and prognosis	17
#814 Inflammatory biomarkers and progression of diabetic kidney disease	17
#2116 Socioeconomic position and incidence of chronic kidney disease in Central Italy	17
#2963 Light chain deposition in the kidney is more frequent in patients with proliferative lupus nephritis	17
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS	17
#543 Cognitive improvement in end stage renal disease patients post transplantation—a prospective observational study	17
#5142 THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT	17
#1297 Approaches to renal response assessment in rare monoclonal immunoglobulin related glomerulopathies	16
MO998: Kidney Donor Risk Index Correlates with the Worse Recipients And Grafts Survival in a Polish Cohort	16
#2439 The association between vitamin D deficiency and sarcopenia in patients with pre-dialysis CKD	16
MO688: Peritoneal Protein Clearance, Inflammation, Nutrition and Overhydration in PD Patients: Looking for the Culprit	16
#2685 SLC34A2 EXACERBATES TUBULAR INTERSTITIAL FIBROSIS VIA INDUCTION OF APOPTOSIS AND CELL CYCLE ARREST IN S PHASE	16
#2450 Alternative splicing in podocytes under mechanical stress: a new perspective for the pathogenic effect of glomerular hypertension	16
#2388 Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome in patients with membranous nephropathy	16
#1704 GLP-1RA versus DPP-4 inhibitors and rates of hyperkalemia and discontinuation of renin-angiotensin system (RAS) blockade in Swedish routine care	16
#1304 Clinical characteristics of acute kidney injury caused by Phytolaccaceae ingestion	16
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS	16
MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts	16
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE	16
#5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE	16
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG	16
FC089: The Absence of Sting Prevents Peritoneal Damage in a Murine Model of Peritoneal Fibrosis	16
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS	16
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL	16
#2394 Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence	16
#672 Intradialytic hypotension and adverse symptoms are not related	15
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA	15
#1914 Comprehensive single-cell sequencing and lipidomics identify diverse injury states and cholesterol dynamics of the PTs in AKI-to-CKD transition	15
#1683 Gut permeability, circulating bacterial fragments, and left ventricular strain in peritoneal dialysis	15
MO490: Fast and High Phosphate Reduction With Lanthanum Dioxycarbonate Versus Selevamer In In-Vivo Study	15
#1906 Lung ultrasound as a valid tool for fluid assessment in dialysis patients: a systematic review	15
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE	15
MO556: Markers of Oxidative Stress and Coronary Calcifications in Chronic Hemodialysis Patients	15
#1916 Infective endocarditis in young female hemodialysis patient: a case report and literature review	15
#801 Impact of delayed graft function on cardiovascular events in kidney transplant recipients	15
#2967 C-reactive protein/serum chloride ratio: a novel marker of all-cause mortality in prevalent chronic haemodialysis patients	15
#289 Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease by upregulating STAT3/NCOA4-mediated ferritinophagy and ferroptosis	15
MO081: Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Kidney Transplant Recipients: A Comparative Study Against Chronic Kidney Disease Patients	15
MO550: Vascular Cells Senescence and Modifications in NRF2 Pathway in a Model of URaEMIC Vascular Calcification	15
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS	15
#1157 Body mass and fluid balance in dialysis: global profiles in Apollo Dial DB	15
#2745 New strategies for capturing undiagnosed chronic kidney disease in patients at risk	15
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE	15
MO275: A Biomarker of Acute Kidney Injury from Proven Renal Origin	15
Are patients with primary glomerular disease at increased risk of malignancy?	14
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN	14
#598 Successful application of allo-hemodialysis in a porcine model of embolization-induced acute kidney injury	14
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis	14
Towards carbon footprint measurement of the ERA congress - five key strategies for greener events	14
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future	14
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis	14
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire	14
FHL2 in arterial medial calcification in chronic kidney disease	14
Peer-reviewing and medical publication	14
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease	14
Hippocampal subfield morphology in regular hemodialysis patients	14
Transition of care of adolescent kidney transplant recipients—a call to action	14
FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients	14
#1936 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)	14
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease	14
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury	13
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease	13
Long-term outcome of kidney function in patients with ANCA-associated vasculitis	13
#4735 USEFULNESS OF CYSTATIN C IN MEASURING RENAL FUNCTION AND PREDICTING METHOTREXATE ASSOCIATED TOXICITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS	13
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies	13
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions	13
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy	13
Time trends in preemptive kidney transplantation in Europe: an ERA registry study	13
#2067 Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning techniques	13
FC006: Sex Differences in the Recognition, Monitoring and Management of Chronic Kidney Disease in Health Care	13
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport	13
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines	13
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI	13
SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis	13
Pediatric kidney care experience after the 2023 Türkiye earthquake	13
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study	13
#5093 DIALYSIS PATIENTS AND BNT162B2MRNA VACCINE TYPE ARE RISK FACTORS FOR IMMUNITY FADING 9 MONTHS AFTER SARS-COV-2MRNA VACCINATION (DIA-VACC STUDY)	12
FC007: The Impact of Sex on the Risk Of Major Adverse Cardiovascular Events in Older Adults with Advanced Chronic Kidney Disease: Results from the Equal Study	12
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN	12
#3520 THE RELATIONSHIPS OF BONE TURNOVER MARKERS AND CEREBRAL WHITE MATTER ALTERATIONS IN PATIENTS UNDERGOING HEMODIALYSIS	12
MO402: Symmetric Dimethylarginine Inhibits Renal Fibrosis in Obstructive Kidneys	12
MO589: Exertion2 Trial: THE Weight Gain Prevention in Renal Transplant Online Study—a Randomized Controlled Feasibility Trial	12
#3459 GLUCOSE-LOWERING THERAPIES IN END STAGE RENAL DISEASE: HOW CAN WE PREDICT THE RISK OF HYPOGLYCAEMIA?	12
#4344 CHANGES IN ENERGY METABOLISM IN THE KIDNEY WITH TUBULOINTERSTITIAL FIBROSIS: AN EX VIVO WHOLE TISSUE 2D-COSY APPROACH	12
MO191: Humoral Immune Response of the Additional Chadox1 NCOV-19 Vaccine Following a Two-Dose Inactivated Whole-Virus SARS-COV-2 Vaccination in Patients on Dialysis	12
#6898 CATHETER RELATED BLOODSTREAM INFECTION IN NON-TUNNELED HEMODIALYSIS CATHETERS IN A RESOURCE-LIMITED HOSPITAL IN MERIDA, YUCATAN, MEXICO	12
#4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD	12
MO019: Preclinical Efficacy of Direct AMPK Activation with a Novel Small Molecule–PXL770–For the Treatment of Autosomal Dominant Polycystic Kidney Disease	12
#6691 COMPREHENSIVE TWO-DAY IN-HOSPITAL ASSESSMENT MODE IS ASSOCIATED WITH THREE-YEAR AND FIVE-YEAR MORTALITY IN PERITONEAL DIALYSIS PATIENTS	12
#5734 RENAL AUTOLOGOUS CELL THERAPY (REACT™) FOR DIABETIC CHRONIC KIDNEY DISEASE: PHASE II TRIAL WITH BILATERAL CORTEX INJECTIONS AND RE-DOSING TRIGGERS	12
#228 APOL1 variants and chronic kidney disease in Morocco: case control study	12